Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, trial of CRB-4001 in patients with fibrosis

Trial Profile

A Phase II, trial of CRB-4001 in patients with fibrosis

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2018

At a glance

  • Drugs CRB-4001 (Primary)
  • Indications Fibrosis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 08 Nov 2018 According to a Corbus Pharmaceuticals media release, Dr. Kunos plans to coordinate this proof-of-concept clinical study at the NIH, following the completion of a phase 1 study by Corbus (299990).
    • 26 Oct 2018 New trial record
    • 18 Oct 2018 According to a Corbus Pharmaceuticals media release, this study will be funded by National Institutes of Health (NIH).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top